Home » About Us » News » Press Release

Press Releases
MMR (Measles, Mumps & Rubella) - 1/9/2015

 

JANUARY 2014

 

 

MMR (Measles, Mumps & Rubella)

MMR is an acronym for Measles, Mumps and Rubella. Most children are generally immunized with the MMR vaccine around 1 year old and receive a booster before attending school (4-5 years old).

The MMR Titer assay is a blood test that measures the antibody titer (i.e. level of immunity) against Measles, Mumps and Rubella. This assay is required by many institutions and organizations, as proof of a certain immunity level or vaccination against these diseases. Examples of organizations with MMR requirements include hospitals and medical clinics (where there is an increased exposure to infectious diseases), schools and universities, and several countries as a requirement before granting a permanent visa.

Meridian Life Science manufactures proven, high-quality antigens for MMR Titer assays. These antigens are used in commercial IgG capture assays for Measles, Mumps and Rubella worldwide.

MERIDIAN'S MMR ANTIGENS

Measles (Rubeloa)

7604
EV9298
C01726M

Native Ag.,  Edmonston strain, IgG detection
Rec. Ag. Nucleoprotein, IgM detection
MAb, purified

 

Mumps

8099
EV9529
C01719M
C01720M
C01721M

Native Ag.,  Enders strain, IgG detection
Native Ag., Grade III, Enders strain, IgM detection
MAb, purified, reacts with nucleoprotein
MAb, purified, reacts with nucleoprotein
MAb, purified, reacts with nucleoprotein

 

Rubella Virus

6075
6076
6200

EV9525
EV9526
10194

Native, Ag., Grade III strain, HPV77 strain, IgG detection
Native Ag., Grade IV, HPV77 strain, IgM detection
Native Ag., RSVP™, HPV77 strain, capsid free for
IgM detection
MAb, purified
MAb, purified
MAb to E1 protein, ascites fluid

 
 

 

> To request more information on our MMR products,
CLICK HERE

 
 

 

 

Contract Manufacturing

Meridian offers a full range of process development and manufacturing capabilities for recombinant proteins, antigens and monoclonal antibodies (cell culture and ascites).
> Learn more

 
 

 

ToRCH Reagents

ToRCH is an acronym for a group of infections that can cause congenital disease. Meridian offers the reagents needed to develop a ToRCH panel suitable for multiple assay formats including IgM and IgM antibody detection, rapid anti-IgM assays, and IFA.
> Learn more

 
 

 

Ebola Reagents

New Ebola monoclonal antibodies and recombinant antigens (Zaire and Sudan strains) suitable for the development of affordable EIA based assays.
> Learn more

 

 

Meet us at our next conference!

Phacilitate Washington 2015
January 26th to 28th, 2015
Grand Hyatt, Washington DC.

> Request a meeting

12th China Association of Clinical Laboratory Practice Expo (CACLP)
Booth B046
March 18th to 20th, 2015
Xiamen International Conference & Exhibition Center.

> Request a meeting

 
 

 

     
 

     
         
back